Key Metrics
CiteScore 

18.4
Scite Index 

0.89 5-Year SI

SNIP 

6.5
Recommended pre-submission checks
Powered by 

Topics Covered on The Lancet Microbe
The Lancet Microbe Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 6300 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in The Lancet Microbe ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in The Lancet Microbe
Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.
- 13 Apr 2027
- The Lancet. Microbe
Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.
- 13 Apr 2027
- The Lancet. Microbe
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).
- 23 Mar 2027
- The Lancet. Microbe
Diagnosis and treatment of female genital schistosomiasis.
- 12 Jan 2027
- The Lancet. Microbe
Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections.
- 13 May 2026
- The Lancet. Microbe
Antimicrobial resistance in bacterial pathogens causing community-acquired and hospital-acquired lower respiratory tract infections (2010-24): a systematic review and meta-analysis.
- 11 May 2026
- The Lancet. Microbe
Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.
- 13 Apr 2027
- The Lancet. Microbe
Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.
- 13 Apr 2027
- The Lancet. Microbe
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).
- 23 Mar 2027
- The Lancet. Microbe
Diagnosis and treatment of female genital schistosomiasis.
- 12 Jan 2027
- The Lancet. Microbe
Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections.
- 13 May 2026
- The Lancet. Microbe
Antimicrobial resistance in bacterial pathogens causing community-acquired and hospital-acquired lower respiratory tract infections (2010-24): a systematic review and meta-analysis.
- 11 May 2026
- The Lancet. Microbe